R21-CA133663/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2009	3
2010	3
2011	1
2012	2
2013	1
2015	1
2016	1
2025	0

1

Targeting cancer-initiating cells with oncolytic viruses.

Cripe TP, Wang PY, Marcato P, Mahller YY, Lee PW. Cripe TP, et al. Mol Ther. 2009 Oct;17(10):1677-82. doi: 10.1038/mt.2009.193. Epub 2009 Aug 11. Mol Ther. 2009. PMID: 19672244 Free PMC article. Review.

2

Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress.

Kaur B, Chiocca EA, Cripe TP. Kaur B, et al. Curr Pharm Biotechnol. 2012 Jul;13(9):1842-51. doi: 10.2174/138920112800958814. Curr Pharm Biotechnol. 2012. PMID: 21740359 Free PMC article. Review.

3

"Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment.

Kaur B, Cripe TP, Chiocca EA. Kaur B, et al. Curr Gene Ther. 2009 Oct;9(5):341-55. doi: 10.2174/156652309789753329. Curr Gene Ther. 2009. PMID: 19860649 Free PMC article. Review.

4

Oncolytic virotherapy reaches adolescence.

Hammill AM, Conner J, Cripe TP. Hammill AM, et al. Pediatr Blood Cancer. 2010 Dec 15;55(7):1253-63. doi: 10.1002/pbc.22724. Epub 2010 Aug 23. Pediatr Blood Cancer. 2010. PMID: 20734404 Review.

5

Neuroblastomas vary widely in their sensitivities to herpes simplex virotherapy unrelated to virus receptors and susceptibility.

Wang PY, Swain HM, Kunkler AL, Chen CY, Hutzen BJ, Arnold MA, Streby KA, Collins MH, Dipasquale B, Stanek JR, Conner J, van Kuppevelt TH, Glorioso JC, Grandi P, Cripe TP. Wang PY, et al. Gene Ther. 2016 Feb;23(2):135-43. doi: 10.1038/gt.2015.105. Epub 2015 Nov 19. Gene Ther. 2016. PMID: 26583803 Free PMC article.

6

Ewing sarcoma: an eponym window to history.

Cripe TP. Cripe TP. Sarcoma. 2011;2011:457532. doi: 10.1155/2011/457532. Epub 2010 Dec 1. Sarcoma. 2011. PMID: 21151695 Free PMC article.

7

Expression of HSV-1 receptors in EBV-associated lymphoproliferative disease determines susceptibility to oncolytic HSV.

Wang PY, Currier MA, Hansford L, Kaplan D, Chiocca EA, Uchida H, Goins WF, Cohen JB, Glorioso JC, van Kuppevelt TH, Mo X, Cripe TP. Wang PY, et al. Gene Ther. 2013 Jul;20(7):761-9. doi: 10.1038/gt.2012.93. Epub 2012 Dec 20. Gene Ther. 2013. PMID: 23254370 Free PMC article.

8

Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus.

Mahller YY, Williams JP, Baird WH, Mitton B, Grossheim J, Saeki Y, Cancelas JA, Ratner N, Cripe TP. Mahller YY, et al. PLoS One. 2009;4(1):e4235. doi: 10.1371/journal.pone.0004235. Epub 2009 Jan 21. PLoS One. 2009. PMID: 19156211 Free PMC article.

9

Molecular engineering and validation of an oncolytic herpes simplex virus type 1 transcriptionally targeted to midkine-positive tumors.

Maldonado AR, Klanke C, Jegga AG, Aronow BJ, Mahller YY, Cripe TP, Crombleholme TM. Maldonado AR, et al. J Gene Med. 2010 Jul;12(7):613-23. doi: 10.1002/jgm.1479. J Gene Med. 2010. PMID: 20603890

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year